Goodman Noah bought KYMR
June 25, 2026 · Form 4 insider transaction
Goodman Noah bought 5,000 shares of Kymera Therapeutics, Inc. at $21.05 per share, a transaction worth $105.3K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
5,000
Price
$21.05
Total value
$105.3K
InsiderGoodman Noah
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJune 25, 2026
Filing dateJune 25, 2026
Shares owned after55,195
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These transactions were effected pursuant to a Rule 10b5-1 trading plan dated December 10, 2025 adopted by the reporting person.